John R. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 149,693 shares at $15.22 ($2.1M) on 2022-05-09, disclosed to the SEC on 2022-05-11.
Open-market sale of $2.1M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.30 | 37,312 | $496K | 23.7% |
| 2 | $13.30 | 37,312 | $496K | 23.7% |
| 3 | $14.20 | 18,966 | $269K | 12.8% |
| 4 | $14.20 | 18,966 | $269K | 12.8% |
| 5 | $15.22 | 18,415 | $280K | 13.4% |
| 6 | $15.22 | 18,415 |
| $280K |
| 13.4% |
| 7 | $15.97 | 307 | $5K | 0.2% |
| Total | $14.01 avg | 149,693 | $2.1M | 100% |
| Filing → |